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By Binding SIRP or Calreticulin/CD91,
Lung Collectins Act as Dual Function Surveillance
Molecules to Suppress or Enhance Inflammation
teraction of receptors on phagocytic cells with the colla-
gen-like tails is suggested and a number of potential
receptors have been considered (Stuart et al., 1997;
Tenner, 1998). However, a cC1q (for collagenous tail C1q
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apoptotic cells (Ogden et al., 2001) wherein the collectin
family molecules bind via their globular heads to the
apoptotic cell surface and mediate ingestion through aSummary
unique form of stimulated macropinocytosis induced by
interaction of their collagenous tails with calreticulin/Surfactant proteins A and D (SP-A and SP-D) are lung
collectins composed of two regions, a globular head CD91 (Ogden et al., 2001). In keeping with these obser-
vations, mice deficient in C1q or SP-D show defectsdomain that binds PAMPs and a collagenous tail do-
main that initiates phagocytosis. We provide evidence in apoptotic cell clearance in vivo (Botto et al., 1998;
Vandivier et al., 2002).that SP-A and SP-D act in a dual manner, to enhance
or suppress inflammatory mediator production de- In sharp contrast to the potentially proinflammatory
effects of PAMP recognition by collectins, mice deficientpending on binding orientation. SP-A and SP-D bind
SIRP through their globular heads to initiate a signal- in SP-A or SP-D exhibit-enhanced inflammatory re-
sponses in the lung to a variety of stimuli (Greene et al.,ing pathway that blocks proinflammatory mediator
production. In contrast, their collagenous tails stimu- 2000; LeVine et al., 2000; Restrepo et al.,1999). SP-D
overexpressing mice show the opposite, i.e., decreasedlate proinflammatory mediator production through
binding to calreticulin/CD91. Together a model is im- inflammation. These observations have led to the sug-
gestion that SP-A and SP-D may exhibit anti-inflamma-plied in which SP-A and SP-D help maintain a non/
anti-inflammatory lung environment by stimulating tory effects in the lung, perhaps to maintain this highly
exposed organ in a quiet, noninflamed state. The appar-SIRP on resident cells through their globular heads.
However, interaction of these heads with PAMPs on ent paradox is maintained in conflicting reports of sur-
factant protein induction (Kremlev and Phelps, 1994;foreign organisms or damaged cells and presentation
of the collagenous tails in an aggregated state to cal- Ofek et al., 2001; Widmann et al., 1999) or suppression
(Arias-Diaz et al., 2000; Greene et al., 1996; Harrod etreticulin/CD91, stimulates phagocytosis and proin-
flammatory responses. al., 1999; Rosseau et al., 1999) of inflammatory mediator
production from macrophages in vitro. The potentially
suppressive effects seem to be mediated by the globularIntroduction
head domains of the surfactant proteins (Sano et al.,
1998) and lead to the hypothesis proposed herein,The collectin family of molecules are generally thought
to function as components of the innate immune system, namely that it is the orientation of the SP-A or SP-D and
acting to protect the host by recognizing pathogen asso- the respective receptors that are engaged, that deter-
ciated molecular patterns (PAMPs) on microorganisms. mines whether the molecules induce or suppress inflam-
They have a unique structure with globular heads ex- mation.
pressing the recognition domains and conserved colla- A number of candidate “receptors” or cell surface
gen-like tails connected through a hinge region. Col- ligands for the globular heads of SP-A have been sug-
lectin monomers are highly oligomerized, first into gested (Poornima et al., 2002; Sano et al., 2000; White
trimers and then further to form complex sertiform or and Strayer, 2002). Recently, both CD14 and TLR2 have
cruciate structures. The group includes mannose bind- been shown to bind SP-A with suppression of stimula-
ing lectin (MBL), conglutinin, the surfactant proteins tion by LPS or peptidoglycan, respectively (Chiba et
SP-A and SP-D, and due to structural similarity, C1q. al., 2001; Murakami et al., 2002). The studies reported
By binding to microorganisms through their globular herein, support a model in which each of the lung col-
heads, the collectin family can enhance or initiate lectins also bind to signal inhibitory regulatory protein
phagocytosis and inflammatory effects. Subsequent in-  (SIRP) thereby activating the tyrosine phosphatase
SHP-1, with downstream blockade of signaling through
src-family kinases and P38 map kinase leading to a more*Correspondence: hensonp@njc.org
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Figure 1. SP-A and SP-D Inhibit Cytokine Production
(A) Human alveolar macrophages or RAW-264.7 cells (B) were pretreated with 10 g/ml SP-A, SP-D, or C1q for 20 min prior to 18 hr LPS
stimulation. Culture supernatants were analyzed by ELISA. The values are presented as percentages of inhibition or stimulation relative to
LPS alone. Addition of 10 M SB-203580 was used as a positive control.
(C) Cells were pretreated with collectins and then stimulated for 20 min with 500 M H2O2. Cytokines were assayed after 18 hr.
general suppression of proinflammatory mediator pro- production, and in fact, enhanced levels above those
produced by LPS alone.duction.
Putting these together leads to an overall model in Surfactant proteins bind to rough LPS (Greene et al.,
1998) and also interact with CD14 (Sano et al., 2000). Inwhich SP-A and SP-D help maintain the non- or anti-
inflammatory environment in the lung due to their stimu- the experiments reported here, a smooth (noncollectin
binding) LPS was employed. However, to confirm sup-lation of the ITIM-containing SIRP on resident alveolar
cells through their globular head, C-lectin domains. pression of stimuli other than LPS the enhanced produc-
tion of cytokines in response to H2O2 was also blockedHowever, when these same domains interact with
PAMPs on foreign organisms, apoptotic cells, or cell by SP-A and SP-D, but not C1q (Figure 1C). In the lung,
the surfactant proteins are generally found bound todebris, presentation of the collagenous tails in an aggre-
gated state to calreticulin/CD91 on the alveolar cells lipids of the pulmonary surfactant through their globular
heads (Ogasawara et al., 1994; Sano et al., 1998). How-now can initiate ingestion, along with proinflammatory
and proimmunogenic responses. ever, SP-A and SP-D still suppressed proinflammatory
mediator production in the presence of surfactant phos-
pholipids containing hydrophobic surfactant compo-
Results nents (SP-B, SP-C) (data not shown).
Surfactant Proteins A and D Inhibit Macrophage
Cytokine Production SP-A and SP-D Inhibit P38 Activation
Blockade of P38 Map kinase prevents production ofThe potential for lung collectins to inhibit production
of proinflammatory cytokines was confirmed initially in inflammatory mediators (Carter and Hunninghake, 2000)
and the P38 inhibitor SB-203580 showed a similar pat-vitro with alveolar macrophages lavaged from normal
human donors. Pretreatment of the cells with SP-A or tern of inhibition as the surfactant collectins (Figure 1B).
SP-A or SP-D blocked LPS stimulation of P38 phosphor-SP-D before 18 hr stimulation with LPS led to reduced
production of cytokines and chemokines (Figure 1A). A ylation in human alveolar macrophages (Figure 2A) and
LPS or H2O2-induced P38 phosphorylation in RAW-264similar effect was seen on the mouse macrophage cell
line, RAW-264 (Figure 1B). Importantly, the nonlung col- cells (Figures 2B and 2C). In contrast, C1q and MBL
induced a modest increase in P38 phosphorylation (Fig-lectins, C1q and MBL were unable to inhibit cytokine
Dual Function of Lung Collectins
15
Figure 2. P38 Phosphorylation and NFB or
AP-1 Reporter Activity Are Inhibited by SP-A
and SP-D
Human alveolar macrophages (A) and RAW-
264.7 cells (B) were pretreated with 10 g/ml
SP-A, SP-D, C1q, or MBL for 20 min prior to
a 5 min exposure to LPS (100 ng/ml). RAW-
264 cells were pretreated with the collectins
prior to addition of H2O2 for 20 min (C). RAW
264.7 cells were transiently transfected with
pNF-B-luc (D) or pAP-1-luc (E) and after 48
hr, incubated in the presence or absence of
SB203580 (10 M) or SP-A (10 g/ml) for 20
min, followed by LPS stimulation (100 ng/ml)
for 4 hr. The luciferase assays were normal-
ized to -galactosidase and are expressed as
fold increase from control.
(F) Phosphorylation of the upstream P38 acti-
vator Vav was analyzed by immunoblot from
RAW-264.7 cells pretreated with the lung col-
lectins prior to LPS stimulation.
(G) MKK6 phosphorylation was determined
after pretreatment for 20 min with the col-
lectins and stimulation with LPS. Immu-
noblots were probed with an anti-PMKK6 an-
tibody.
ure 2B). SP-A and SP-D also inhibited luciferase genera- to increased tyrosine phosphorylation of SIRP (Figure
tion by NFB or AP-1 reporter constructs in RAW-264 3C). The lung collectins also initiated rapid association
cells (Figures 2D and 2E). C1q enhanced this (Figure of SHP-1 with SIRP as shown by coimmunoprecipita-
6C). Phosphorylation of potential upstream signaling tion (Figure 3D).
molecules, Vav, and MKK6 was inhibited by both SP-A
and SP-D (Figures 2F and 2G) but, not C1q (data not
shown). Hck activity was also inhibited by SP-A and SP-A and SP-D Bind Directly to SIRP
SP-D but not C1q (data not shown). To demonstrate interaction of the collectins with SIRP,
SP-A, SP-D were shown to prevent binding of an anti-
SIRP antibody to RAW-264 cells (Figures 4A and 4B).SP-A or SP-D, but Not C1q, Activates
Binding of a control antibody, F480, was not affectedSHP-1 and SIRP
(data not shown). In the other direction, CD47 (as an Fc-The proceeding experiments indicated that lung col-
CD47 fusion product), a known ligand for SIRP pre-lectin suppression is likely an early upstream event in-
vented binding of FITC-SP-A (Figure 4C). C1q stainingvolving decreased phosphorylation of src family kinases
was unaffected and human Fc fragments did not altersuch as Hck, either from reduced activation and/or in-
SP-A or C1q binding (data not shown).creased effects of a tyrosine phosphatase. As shown in
Furthermore, anti-SIRP and FITC-labeled SP-A (butFigures 3A and 3B, SP-A and SP-D (but not C1q) were
not C1-q) colocalized on the cell surface (Figure 4D).found to increase both phosphorylation and phospha-
COS cells transfected with a SIRP construct and whichtase activity of SHP-1.
expressed this protein on their surface, (data not shown)Activation of SHP-1 suggested that the collectins
were found to bind FITC-labeled SP-A and SP-D (Figurewere binding to a surface receptor or complex con-
4E) but not C1q. Finally, RAW macrophages pretreatedtaining an ITIM domain. SIRP is a heavily glycosylated,
with a blocking anti-SIRP antibody prior to the additionITIM-containing, membrane receptor present on the sur-
of the surfactant proteins showed restoration of LPSface of a number of cell types (Veillette et al., 1998).
Thus, addition of SP-A or SP-D, but not C1q, was found induced cytokine production (Figure 4F).
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Figure 3. SP-A and SP-D Activate SHP-1
and SIRP
(A) SP-A treatment results in SHP-1 phos-
phorylation. RAW-264 cells were stimulated
with SP-A for 20 min, immunoprecipitated for
SHP-1, and probed with an antiphosphotyro-
sine antibody.
(B) SHP-1 is activated by surfactant proteins.
SP-A, SP-D or C1q were added for 2, 5, or
20 min and SHP-1 activity measured. Bars
represent percent enhancement of SHP-1
phosphatase activity compared to control
cells. Addition of the lung collectins results
in SIRP phosphorylation (C) and recruitment
of SHP-1 (D). RAW-264 cells were stimulated
with SP-A, SP-D or C1q (10 g/ml) for 10
min, lysed, and SIRP immunoprecipitated.
Immunoblots were probed with an antiphos-
photyrosine antibody (C) or an anti-SHP-1 an-
tibody (D).
SP-A and SP-D Inhibition Is Based on Globular Lung Collectins Exhibit a Dual Inflammatory
Role In VivoHead Binding to SIRP
The effect of surfactant proteins was examined in anThe data in Figure 1 demonstrated that SP-A and SP-D
inflammatory model in the murine peritoneum, a siteinhibited P38 activation and proinflammatory mediator
lacking endogenous and potentially interfering SP-A andproduction whereas C1q and MBL enhanced. All four
SP-D. Mice injected intraperitoneally with SP-A one hourcollectins share similar collagenous tails but differ in
prior to the initiation of inflammation by LPS showedtheir globular heads. To confirm that the anti-inflamma-
suppression of proinflammatory mediator production attory activities of SP-A and SP-D were mediated by their
this site (Figure 7A). As predicted from the model, C1q,globular head regions, a variety of SP-A and SP-D mu-
which lacks the ability to bind and activate SIRP, en-tants were examined. Collagen domain deletion mutants
hanced cytokine production, presumably by acting on(CDM mutants) exhibit a functional head domain but no
calreticulin/CD91 through its collagenous tails.functional tails (Ogasawara and Voelker, 1995). Both the
To determine the effect of collectin orientation in theSP-A and SP-D CDM proteins were able to suppress
presence of a natural ligand, SP-A or C1q were addedcytokine production and P38 phosphorylation (Figures
to RAW macrophages simultaneously with necrotic cell5A and 5B). In addition, FITC-labeled SP-A CDM (but not
debris, which express ligands for the globular heads.SP-A tails) bound to COS cells transfected with SIRP
This would be expected to direct the collagenous tails(Figure 5C).
toward the responding macrophage or tissue cell. Ne-
crotic cell debris did not significantly enhance cytokine
Stimulation of Macrophage Inflammatory production alone, however, in the presence of either
Responses by the Collagenous Tail Domains SP-A or C1q, proinflammatory mediator production was
of the Pulmonary Collectins and Calreticulin enhanced (Figure 7B). This suggests that a natural ligand
In contrast to the effect of SIRP ligation by SP-A or for the globular heads not only promotes engulfment
SP-D globular heads, collectin tail domains may actively (data not shown), but also the production of proinflam-
enhance or stimulate proinflammatory mediator produc- matory mediators. To confirm that this effect was medi-
tion (Figures 6A–6C). Thus, the two collectins that lack ated through CD91, cell debris plus collectins was
SIRP binding and activating properties, C1q and MBL, shown unable to elicit a proinflammatory response in
each enhance P38 activation, NFB reporter activity, CD91-deficient mouse embryonic fibroblasts (MEF)
and production of mediators. Importantly, isolated SP-A while a proinflammatory response occurred in wild-type
collagenous tails or mutants lacking functional head MEFs (data not shown).
groups (SP-A switch) did the same, enhancing the ef- To examine the effect of orientation in vivo, SP-A or
fects of LPS stimulation but also directly initiating the C1q were added to the cell debris (to allow globular
production of cytokines, P38 phosphorylation, and acti- head binding and collagenous tail presentation) before
vation of NF-B (Figures 6A, 6B, and 6C). Similar effects injection into the peritoneum. For both molecules, in-
were seen on cells from C3H-HeJ mice lacking func- flammatory mediator generation was enhanced (Fig-
tional TLR-4 and LPS responses (data not shown). To ure 7C).
support a role for surface calreticulin in the proinflamma- To investigate the potential hierarchy between inhibi-
tory action of the collectins, an antibody to calreticulin tory or enhancing signals, macrophages were pre-
was shown to block induction of inflammatory mediator treated with SP-A for 30 min prior to addition of necrotic
production by SP-A tails (Figure 6D) or C1q (data not cell debris preincubated with C1q. As predicted, pre-
treatment of the macrophages with SP-A decreased theshown).
Dual Function of Lung Collectins
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ability of C1q coated debris to enhance cytokine produc- hand, they also appear to be important in regulating
pulmonary inflammatory responses. The degree of in-tion (Figure 7D).
flammation has consistently been related to the levels
of SP-A or SP-D in knockout or overexpressing miceDiscussion
with decreased levels associated with increased inflam-
mation and vice versa. It is suggested that the dualThe lung collectins, SP-A and SP-D, like their counter-
function model outlined in Figure 8 explains these appar-parts MBL and C1q, act as innate immune system mole-
ent dichotomous effects.cules that recognize foreign organisms, cell debris, apo-
Similar conflicting data have been reported in studiesptotic cells, and the like to mediate their removal by
of SP-A on macrophages in vitro suggesting either anphagocytosis. As with other innate immune system mol-
increase (Blau et al., 1994; Kremlev and Phelps, 1994;ecules they may also initiate inflammatory responses
Ofek et al., 2001; Widmann et al., 1999) or decreaselinked to host defense and induction of adaptive immu-
(Arias-Diaz et al., 2000; Greene et al., 1996; Harrod etnity. It is suggested that they act by recognizing PAMPs
al., 1999; Rosseau et al., 1999; Sano et al., 1999) ofthrough binding sites on their globular heads and by
inflammatory mediator production. Complete explana-stimulating phagocytic cells via binding of their collage-
tions for these varied effects are likely complex and maynous tails to calreticulin on the cell surface. This medi-
reflect differences in the cells examined, the stimuli usedates intracellular signaling through CD91 (LRP). In com-
and the preparations of SP-A employed. However, theplete contrast, SP-A and SP-D (but, not MBL or C1q)
results are also consistent with the dual effect outlinedalso serve as anti-inflammatory stimuli that, we suggest,
in Figure 8. Binding to macrophages by the C-lectinhelp maintain normal tissue homeostasis at sites such
domains is suggested to block stimulatory signalingas the lung that are constantly exposed to injurious or
pathways leading to NF-B- (and AP-1) mediated tran-inflammatory stimuli. SP-A appears to be localized only
scription and/or subsequent translation of the proin-to the lungs, but SP-D is also found at other mucosal
flammatory mediators. On the other hand, interactionsurfaces where it may serve a similar protective function.
of the collagenous tail regions of the collectins withAnti-inflammatory effects appear to be mediated by
calreticulin/CD91 is suggested to induce or enhancebinding of SP-A and SP-D head groups to the ITIM-
production of proinflammatory mediators. This dual ef-containing molecule, SIRP, leading to suppression of
fect is hypothesized to represent a unique set of regula-mediator production. These proposed dual effects are
tory and discriminatory functions for collectins in themodeled in Figure 8. They lead to the suggestion that
lung (or, for that matter in other mucosal sites knownthe lung collectins by themselves act as dual function
to express SP-D) leading to both protection from inflam-surveillance molecules, serving normally to maintain a
mation by casual environmental stimuli and the highnoninflammatory environment, but, upon recognition
oxygen tension at this site but also, when invaded orand binding to foreign materials, reversing both their
injured, to the opposite effect, namely initiation of pro-orientation and their effects to initiate host defense reac-
tective inflammatory responses.tions, inflammation, and enhancement of adaptive im-
In this model, binding of SP-A or SP-D to a bacterium,munity.
virus, yeast, or damaged cell through recognition by the
globular heads would present the collagen tails to the
The Host Defense and Proinflammatory
macrophage or other responding cells, likely in an aggre-
Effects of SP-A and SP-D gated form optimal for stimulation of this proinflamma-
The effects include binding foreign material, opsoniza- tory function. The concept would, for example explain
tion, enhanced clearance, and inflammation in response the observations of Rosseau et al. (1999) that soluble
to potentially injurious stimuli. In addition, we have sug- SP-A was inhibitory to Candida-induced cytokine pro-
gested that the collectins have been suborned, not only duction, even when preincubated with the macrophages,
for recognizing foreign or “danger” signals, but also whereas presentation of the SP-A on the Candida or by
unwanted and damaged cells within the host itself (Og- precoating the plate on which the macrophages were
den et al., 2001; Schagat et al., 2001; Vandivier et al., cultured, was not. These latter two circumstances, we
2002). Data supporting the importance of SP-A in host would suggest, led to collagen tail stimulation of mem-
defense comes from studies of SP-A deficient mice brane calreticulin and CD91. In like manner, Sano et
which exhibit increased susceptibility to airway chal- al. (Sano et al., 1999) demonstrated inhibition of TNF
lenge with group B Streptococci, Pseudomonas aerugi- production by SP-A if the macrophages were presented
nosa, or Staphylococcus aureus. However, despite the with smooth LPS (with which the SP-A C-lectin domains
decreased resistance, the mice also developed more do not interact) but mild stimulation of this cytokine if
severe pulmonary inflammation which was corrected by SP-A binding, rough forms of LPS were used.
instillation of purified SP-A (LeVine et al., 1998; LeVine C1q has previously been reported to stimulate produc-
et al., 1999). SP-D is also reported to act in pulmonary tion of IL-8, IL-6 and MCP-1 (van den Berg et al., 1998).
host defense based on its binding to a variety of microor- This work is confirmed herein as C1q (and MBL) not only
ganisms (Kuan et al., 1992; Restrepo et al., 1999) and enhanced an LPS effect, but also induced the mediators
rough, but not smooth forms of LPS (Greene et al., 1998). on their own or when bound to cellular debris. C1q and
Here again, however, SP-D/ mice exhibit increased MBL do not exhibit anti-inflammatory functions through
pulmonary inflammatory responses (LeVine et al., 2000). their globular head groups (do not bind SIRP) and are
The emerging theme from these studies is that the proposed to mediate the proinflammatory effect through
lung collectins recognize a significant number of micro- their collagenous tails. SP-A tails, or SP-A and SP-D
constructs lacking head group function also enhancedorganisms and play a role in their clearance. On the other
Cell
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Figure 4. SP-A and SP-D Bind Directly to SIRP
SP-A and SP-D block anti-SIRP- binding to the cell surface. Cells were pretreated with the lung collectins or C1q prior to staining with an
anti-SIRP antibody (A) flow cytometry or (B) immunofluorescence.
(C) CD47 blocks SP-A binding to macrophages. Macrophages were pretreated with CD47 for 20 min prior to addition of FITC labeled SP-A
or C1q and analysis by flow cytometry.
(D) SP-A colocalizes with SIRP on the cell surface. RAW-264 cells were examined after costaining with FITC-labeled SP-A or C1q and anti-
SIRP antibody.
(E) COS cells were transiently transfected with SIRP or vector control for 24 hr and binding of FITC-labeled SP-A, SP-D, or C1q to the cells
detected by flow cytometry.
(F) Pretreatment of RAW cells with anti-SIRP reverses the inhibitory effect of SP-A. Cytokines were measured after overnight culture from
cells pretreated with anti-SIRP or an isotype control followed by a 30 min incubation with SP-A and then stimulation with LPS.
and directly induced, production of proinflammatory ity to the cell. Thus, capture of LPS by SP-A or SP-D
could enhance interaction of the LPS with Toll-like re-mediators as well as activation of P38 Map kinase and
induction of NFB and AP-1 reporter constructs. Initial ceptors on a target cell to which the complex had bound
through its tail, in addition to any stimulatory effect theinteraction of SP-A with cell debris to orient the molecule
for collagenous tail presentation before injection into tail binding may have by itself.
the peritoneum led to a proinflammatory response.
Collectins can bind via their collagenous tails to cell The Anti-Inflammatory Effects of SP-A and SP-D
In the normal environment of the resting lung, we sug-surface calreticulin. While it is not yet clear how this
endoplasmic reticulum, calcium binding, and chaperone gest that SP-A and SP-D engage the ITIM-containing
inhibitory receptor SIRP expressed on mononucleargains access to this site, most cell types examined do
express calreticulin on their surface (Arosa et al., 1999; phagocytes but also by pulmonary epithelial cells (data
not shown). This would maintain a general suppressionGoicoechea et al., 2000). Recent studies have suggested
that calreticulin interacts with, and signals through, of mild activation by casual stimuli such as inhaled parti-
cles, LPS, lysed cells, or the stray effects of oxidantsCD91 (Basu et al., 2001; Orr et al., 2002). Data presented
herein support this route for collagenous tail stimulation. resulting from the high oxygen tension. An alternative
role for lung collectins in protection against oxidant ef-While not directly investigated, we suspect that signifi-
cant aggregation of the collectin tails is required for fects may involve direct effects on lipid peroxidation
(Bridges et al., 2000). Oxidants initiate inflammatory re-optimal stimulation of the calreticulin/CD91 system (Og-
den et al., 2001; van den Berg et al., 1998) suggesting actions and many defense mechanisms have been de-
scribed, particularly those that remove or divert the oxi-either low affinity interactions and/or multimerization as
a mode of activation of this receptor complex. dants themselves. Here we are suggesting two different
modes of antioxidant effect via SIRP blockade of bothIn addition to the direct stimulation of proinflammatory
mediator through calreticulin and CD91, interaction of the active generation of toxic oxidants and suppression
of the proinflammatory consequences of oxidant action.collagenous tails with cell surface receptors might also
be expected to bring organisms, cells, or molecules These mechanisms would add to the enormously redun-
dant protective processes required for survival in ourcaptured by the globular head groups into close proxim-
Dual Function of Lung Collectins
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Figure 5. SP-A and SP-D Inhibition of Macro-
phage Activity Is Based on Binding to SIRP
via Their Globular Head Groups
(A) RAW-264.7 cells were treated with SP-A
and SP-A CDM mutants (nonfunctional tail
region) prior to LPS stimulation. The values
are percentage of inhibition or increase rela-
tive to LPS alone.
(B) SP-A functional heads, but not tails, inhibit
LPS induced P38 phosphorylation. RAW-264
cells were pretreated with (10 g/ml) SP-A,
SP-A CDM mutants, or SP-A tails prior to acti-
vation with LPS for 20 min. P38 phosphoryla-
tion was detected by immunoblot.
(C) SP-A heads but not tail regions bind to
SIRP. COS cells were transiently trans-
fected with SIRP or vector control and bind-
ing of FITC-labeled SP-A, SP-A CDM mu-
tants, or SP-A tails (as control) to the cells
was examined by flow cytometry.
highly toxic, oxygen-rich environment. Effects of the tors. The lung collectins inhibited P38 activation as well
as known upstream candidate molecules Vav and thelung collectins to bind and divert LPS or to block its
interaction with CD14 or TLRs (Sano et al., 2000) would src-family kinase member Hck. Hck is of interest, as a
recent report indicates that its overexpression leads toserve only to enhance the overall anti-inflammatory
effect. enhanced pulmonary inflammation (Ernst et al., 2002).
It is important to note that our data do not excludeSP-A and SP-D, but not C1q or MBL, inhibited the
production of representative proinflammatory cytokines similar inhibitory effects on other src-family kinases, Hck
was the one examined herein. The inhibition of intracel-and chemokines from LPS-stimulated cells both in vitro
and in vivo. Importantly, suppression was not seen with lular signaling pathways was also not limited to P38
Map kinase as JNK phosphorylation was also prevented,lung collectin constructs lacking globular head function
but was unaltered in the absence of collagenous tails. which may, in part, explain effects on AP-1-driven in-
flammatory mediators such as the monocyte chemoat-Inhibition also extended to a variety of proinflammatory
stimuli including H2O2 or cell debris. tractant MCP-1.
The lung collectin effects were attributed either toThe inhibitory effect was seen on NFB and AP-1
reporter constructs and was very similar in profile and blockade of Hck activation or, more likely, to activation
of a tyrosine phosphatase. An initial candidate, CD45,extent to the blockade seen with P38 Map kinase inhibi-
Figure 6. Collagenous Tails Stimulate Cyto-
kine Production and P38 Phosphorylation by
Binding to CD91/Calreticulin
Collagenous tail regions of collectins lead to
proinflammatory mediator production after
18 hr (A) and P38 phosphorylation as early as
5 min (B). For NF-B activation (C), RAW 264.7
cells were transiently transfected with pNF-
B-luc and after 48 hr, stimulated with C1q,
SP-A tails, or the SP-A mutant “Switch” (the
Switch mutant contains a functional tail do-
main but does not possess a functional head
region) (10 g/ml) for 4 hr. Luciferase activity,
normalized to -galactosidase, is expressed
as fold increase from control.
(D) Collagenous tails bind/act though CD91/
Calreticulin. RAW 264.7 cells were pretreated
with 2 g/ml of anticalreticulin or an isotype
control for 20 min prior to addition of SP-A
tails. Cells were stimulated for 18 hr and in-
flammatory mediators detected by ELISA.
Cell
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Figure 7. Lung Collectins Exhibit a Dual In-
flammatory Role In Vivo
(A) SP-A blocks LPS induced proinflamma-
tory cytokines in vivo. Mice were injected in-
traperitoneally with 50 g of SP-A for 1 hr,
and inflammation initiated with a second in-
jection of LPS (50g) or PBS. The peritoneum
was lavaged after 90 min and cytokines mea-
sured by ELISA.
(B) Collectins interacting with cellular debris
enhance cytokine production. Necrotic cell
debris created by freeze/thawing Jurkat
T cells was added along with SP-A or C1q to
RAW macrophages and samples were col-
lected for ELISA after 18 hr.
(C) Mice were injected intraperitoneally with
necrotic cell debris mixed with 25 g of SP-A
or C1q. After 6 hr, the peritoneum was la-
vaged and cytokine levels measured.
(D) Collectin ligation of SIRP partially blocks
CD91 signaling. RAW 264.7 macrophages
were pretreated with SP-A for 30 min prior to
the addition of C1q-coated cellular debris.
Cytokines were measured after 18 hr.
did not appear involved as determined with CD45 null tion of SHP-1 follows. In the studies reported here, bind-
ing of anti-SIRP antibodies to macrophages wasmice. However, SIRP (also known as SHPS-1) which
activates the tyrosine phosphatase, SHP-1 was impli- reduced in the presence of SP-A or SP-D. Transfection
of SIRP into COS cells rendered them able to bindcated. Data are presented to show SIRP phosphoryla-
tion and SHP-1 activation and phosphorylation during the lung collectins. Data were also presented showing
colocalization of the surfactant proteins with SIRP. Westimulation with SP-A or SP-D. Once again, the control
collectin family members, C1q and MBL were inactive. do not know the domains on SIRP recognized by the
globular heads of SP-A and SP-D, nor whether theseIt is noteworthy that SHP-1 deficient mice also develop
spontaneous pulmonary inflammation (Ward, 1978). are the same or different for each collectin. However,
SIRP’s glycosyl groups are reasonable candidates.SIRP is a heavily glycosylated, ITIM-containing,
transmembrane protein. Ligation of its extracellular do- A potential mechanism is proposed in which lung col-
lectins bind by their globular heads to SIRP under nor-main by natural ligands such as CD47 or by crosslinking
antibody leads to tyrosine phosphorylation by unknown mal conditions. SIRP activation would suppress the
production of proinflammatory mediators potentiallykinases (Kharitonenkov et al., 1997). Recruitment, phos-
phorylation (by receptor tyrosine kinases), and activa- triggered by daily insults to the lungs thereby main-
Figure 8. Model for Dual Effects of Lung Sur-
factant Proteins
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HEPES, 150 mM NaCl, 1 mM DTT, 0.5% Triton X-100, and 1 Prote-taining an immunologically quiet and noninflamed envi-
ase Inhibitor Cocktail Set I (Calbiochem, San Diego CA)], resolvedronment. However, when these same head domains in-
on 10% SDS-PAGE, and blotted to a nitrocellulose membrane. Theteract with PAMPs on foreign organisms, apoptotic
membranes were probed with a phosphospecific antibody to P38,
cells, or cell debris, presentation of the collagenous tails or Mkk6. To confirm equal loading, the membranes were stripped
in an aggregated state to calreticulin/CD91 on the cells and reprobed for P38, or Mkk6 protein.
can initiate phagocytosis and/or proinflammatory and
proimmunogenic responses. In addition, the collectins Transient Cell Transfection and Reporter Gene Assays
pNF-kB-Luc (kB4, 6x, Clontech, Palo Alto CA) and pAP-1-Luc (AP-1,would also aid in the resolution of inflammation by con-
7x, Stratagene, La Jolla CA) luciferase reporter gene constructstributing to the clearance of apoptotic cells. Thus, a
were kindly provided by Dr. Annemie Van Linden, Denver, Colorado,unique dual inflammatory role for these important com-
and the SIRP- constructs were provided by Dr. A. Ullrich, Mat-
ponents of the innate immune system is proposed. insried, Germany. RAW 264.7 cells (3.0  105/ml) were cultured
overnight and transfected with Lipofectamine Plus according to the
Experimental Procedures manufacturer’s instruction. The cells were pretreated with SP-A,
SP-D, or C1q as above and luciferase activity, normalized to -Gal,
Antibodies and Reagents was measured 4 hr after LPS stimulation.
Antiphosphotyrosine 4G10, anti-SIRP, and anti-VAV were from Up-
state (Lake Placid, NY) and anti-SHP-1 from Santa Cruz (San Diego,
Inhibition of VAV PhosphorylationCA). Anti-CRT antibody was from Affinity BioReagents (Golden, CO),
RAW 264 macrophages were pretreated as above for 20 min priorantiphospho-P38 and phospho-Mek6 from Cell Signaling Technol-
to stimulation with 100 ng/ml of LPS. After 5, 10, and 20 min, samplesogy (Beverly, MA) and anti-SIRP P84 was a gift from Dr. A. Ullrich,
were lysed in lysis buffer (20 mM Tris, 140 mM NaCl, 2.6 mM CaCl2,Max-Plank-Institut fur Biochemie, Martinsried, Germany. SB203580
1 mM MgCl2, 1% NP-40, and 10% glycerol) containing proteasewas obtained from Calbiochem (San Diego, CA) and smooth LPS
inhibitors and 10 g/ml NaPO4. Samples were immunoprecipitated(E. coli 0111:B4) from ListBiological Laboratories (Campbell, CA).
for 2 hr and lysates run on a 10% SDS-PAGE gel. Immunoblots wereMice used were 6-week-old female C57/Blk6 from Harland-
probed with antiphosphotyrosine 4G10 antibody and equal loadingSprauge-Dawley (Frederick, MD).
confirmed by stripping and reprobing with an anti-Vav antibody.
Cell Culture
SHP-1 Activation AssayMurine RAW 264.7 and J774 macrophages (ATCC) were cultured in
RAW 264 macrophages were incubated overnight, SP-A or SP-DDMEM supplemented with 10% heat-inactivated FBS, 2 mM
(10 g/ml) added for various times and samples lysed. SupernatantsL-glutamine, 100 mg/ml streptomycin, and 100 U/ml penicillin under
were collected and immunoprecipitated with 1 g of anti–SHP-1 ora humidified 5% CO2 atmosphere at 37C.
an isotype control. Samples were resuspended in 50 l of assayAlveolar macrophages were isolated by bronchoalveolar lavage
buffer (Upstate Phosphatase assay kit) and 25 l aliquots examinedfrom normal human volunteers and cultured as described previously
against a phosphopeptide according to the manufacturers instruc-(Vandivier et al., 2002).
tions. Phosphate concentration/well was determined by comparison
of absorbance to a standard curve fit.
Isolation and Purification of Collectins
SP-A was isolated from whole lung lavage fluid taken from patients
SIRP and SHP-1 Immunoprecipitation and Western Blotswith pulmonary alveolar proteinosis, as previously described (Allen
Cells were incubated for 10 min with the indicated stimuli then lysedet al., 2001). SP-D was expressed in CHO cells and stripped of LPS
in 500 l of lysis buffer. Lysates were immunoprecipitated with 1after purification as described previously (Vandivier et al., 2002).
g anti-SIRP or anti-SHP-1 antibody, samples run on a 10% gel,MBL was purified from acute-phase human plasma as reported
transferred, and probed with antiphosphotyrosine 4G10 overnight.previously (Ogden et al., 2001). Purified human C1q came from
Immunoblots were stripped and reprobed with either anti-SIRP orQuidel Corp (San Diego, CA). SP-A collagenous tails were prepared
anti-SHP-1 to confirm equal protein levels.as described (Ogden et al., 2001; Reid, 1976). Briefly, SP-A was
dialyzed overnight against 0.15 M NaCl, 0.1 M Na acetate, [pH 4.5],
and incubated for 4 hr at 37C with 0.3 mg/ml pepsin. After centrifu- SIRP and Collectin Localization
gation for 10 min at 10,000 g, the supernatant was fractionated on RAW 264 macrophages were stained on ice with 2 g of anti-SIRP
an ACA34 column and tails eluted with Tris-buffered saline with 5 P84 antibody in PBS  1% HSA and 2% serum for 45 min. Samples
mM Ca2. were washed twice prior to addition of a Cy3 anti-rat antibody (Jack-
son, West Grove PA). Staining was analyzed by flow cytometry or
fluorescence microscopy. For colocalization studies, FITC-labeledStimulation of Cytokines
SP-A or C1q was added after the secondary antibody. For blockingMacrophages were cultured at 1  106 cell/ml overnight and then
studies, cells were pretreated with 10 g/ml of SP-A, C1q, Fc-CD47,pretreated with 10 g of the collectins or 25 M SB203580 for 20
or human Fc fragments prior to the addition of anti-SIRP antibodymin prior to 18 hr LPS stimulation. Supernatants were centrifuged
or FITC-labeled SP-A or C1q. Before microscopic analysis samplesto remove cellular debris and stored at 70C until analyzed by
were fixed in 2% paraformaldehyde for 15 min on ice and thenELISA. Alternative stimuli included 500 M H2O2 or necrotic cell
washed 5 times in PBS. Nuclei were stained with (5 g/ml) Hoechstdebris. This latter comprised broken cell membranes and cytosol
#33258 (Calbiochem). Images were collected with Slidebook on ain the 15,000  g supernatant of five cycles of freeze-thaw treated
Leica DMRXA microscope at 62 magnification.of Jurkat T cells. Mice were injected intraperitoneally with 50 g of
Data are presented as mean 	 SEM of at least three independentSP-A or C1q or 1 ml of sterile PBS and 1 hr later with 50 g of LPS,
experiments and the gels shown are representative of three or four200 g of cell debris, or sterile PBS as a control. The peritoneal
separate experiments.cavity was lavaged after 90 min. Cytokines (TGF-1, TNF-, MCP-1,
and either MIP-2 for mouse or IL-8 for human cells) were measured
by ELISA using antibodies from R&D Systems (Minneapolis, MN) as Acknowledgments
described (Fadok et al., 2001).
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